Spots Global Cancer Trial Database for carcinoma of unknown primary

Every month we try and update this database with for carcinoma of unknown primary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary	NCT00357630	Carcinoma of Un... Pain	gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)	NCT03391973	Carcinoma of Un...	Pembrolizumab I...	18 Years -	AHS Cancer Control Alberta
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction	NCT01366144	Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc...	Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib	18 Years -	National Cancer Institute (NCI)
Cancer Genetic Testing in Ethnic Populations	NCT04475640	Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma	Biospecimen Col... Genetic Testing	18 Years -	Mayo Clinic
Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS	NCT04189107	Analgesia Surgery Cancer of Head ... Oropharyngeal C... Carcinoma of Un... Pain, Postopera... Postoperative P...	Dexamethasone Placebo	18 Years -	Rigshospitalet, Denmark
Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin	NCT00003558	Carcinoma of Un...	carboplatin etoposide fluorouracil leucovorin calc... paclitaxel	18 Years -	National Cancer Institute (NCI)
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary	NCT00873119	Carcinoma of Un...	belinostat, car... carboplatin, pa...	18 Years -	Valerio Therapeutics
Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)	NCT03391973	Carcinoma of Un...	Pembrolizumab I...	18 Years -	AHS Cancer Control Alberta
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.	NCT00003943	Carcinoma of Un... Lung Cancer	filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo...	18 Years -	Fox Chase Cancer Center
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy	NCT01624220	Spinal Tumor	Spinal SBRT (St... Spinal SBRT (Hi... Gold Seed Impla... Questionnaires	18 Years -	M.D. Anderson Cancer Center
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	NCT00004922	Carcinoma of Un... Neuroendocrine ... Neuroendocrine ...	irinotecan hydr...	18 Years -	Memorial Sloan Kettering Cancer Center
RAPA-201 Therapy of Solid Tumors	NCT05144698	Solid Tumor Breast Cancer Small Cell and ... Triple Negative... Gastric Cancer Esophageal Aden... Gastric Junctio... Esophageal Squa... Head and Neck C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Squamous Cell C... Carcinoma of Un... Bladder Cancer Malignant Melan...	RAPA-201 Rapamy... Chemotherapy Pr...	18 Years -	Rapa Therapeutics LLC
Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary	NCT02764216	Head-and-neck C... Carcinoma of Un...	Elective mucosa...	18 Years - 70 Years	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary	NCT00357630	Carcinoma of Un... Pain	gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Eastern Cooperative Oncology Group
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer	NCT00003582	Carcinoma of Un... Head and Neck C...	amifostine trih... cisplatin fluorouracil paclitaxel quality-of-life... radiation thera...	18 Years - 120 Years	University of Miami
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	NCT00004922	Carcinoma of Un... Neuroendocrine ... Neuroendocrine ...	irinotecan hydr...	18 Years -	Memorial Sloan Kettering Cancer Center
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors	NCT05887492	Non Small Cell ... Solid Tumors, A... Endometrial Can... Pancreatic Canc... Cervical Cancer Breast Cancer Carcinoma of Un...	TNG260 Pembrolizumab	18 Years -	Tango Therapeutics, Inc.
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer	NCT03010150	Carcinoma of Un... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Head... Metastatic Mali... Pathologic Stag... Pathologic Stag... Pathologic Stag... Stage I Hypopha... Stage I Nasopha... Stage II Hypoph... Stage II Laryng... Stage II Nasoph... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Nasop... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Nasoph... Stage IV Oropha... Stage IVA Hypop... Stage IVA Laryn... Stage IVA Nasop... Stage IVA Oroph... Stage IVB Hypop... Stage IVB Laryn... Stage IVB Nasop... Stage IVB Oroph...	Biospecimen Col... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin	NCT00004005	Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi...	fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera...	- 24 Years	St. Jude Children's Research Hospital
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.	NCT00003943	Carcinoma of Un... Lung Cancer	filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo...	18 Years -	Fox Chase Cancer Center
Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary	NCT00873119	Carcinoma of Un...	belinostat, car... carboplatin, pa...	18 Years -	Valerio Therapeutics
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction	NCT01366144	Breast Carcinom... Carcinoma of Un... Endometrial Car... Esophageal Carc... Liver Failure Lung Carcinoma Malignant Head ... Malignant Testi... Melanoma Metastatic Mali... Ovarian Carcino... Renal Failure Unresectable Ma... Urothelial Carc...	Carboplatin Laboratory Biom... Paclitaxel Pharmacological... Veliparib	18 Years -	National Cancer Institute (NCI)
Cancer Genetic Testing in Ethnic Populations	NCT04475640	Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma	Biospecimen Col... Genetic Testing	18 Years -	Mayo Clinic
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs	NCT04985357	Stage III Breas... Stage IV Breast... Stage III Lung ... Stage IV Lung C... AML Multiple Myelom... Carcinoma Carcinoma, Panc... Carcinoma of Lu... Carcinoma, Non-... Carcinoma Breas... Carcinoma Prost... Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Neur... Carcinoma, Smal... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Es... Carcinoma Cervi... Carcinoma, Thym... Carcinoma, Duct... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Malignant Pleur... Malignant Ascit... Mesothelioma Cholangiocarcin...		18 Years -	Travera Inc
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin	NCT00022178	Carcinoma of Un...	cisplatin cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil vincristine sul...	18 Years -	National Cancer Institute (NCI)
Elective Mucosal Irradiation in Head-and-Neck Cancer of Unknown Primary	NCT02764216	Head-and-neck C... Carcinoma of Un...	Elective mucosa...	18 Years - 70 Years	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer	NCT00002507	Carcinoma of Un... Head and Neck C...	mitomycin C porfiromycin brachytherapy radiation thera...	20 Years - 80 Years	Yale University
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors	NCT05887492	Non Small Cell ... Solid Tumors, A... Endometrial Can... Pancreatic Canc... Cervical Cancer Breast Cancer Carcinoma of Un...	TNG260 Pembrolizumab	18 Years -	Tango Therapeutics, Inc.
Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary	NCT00357630	Carcinoma of Un... Pain	gemcitabine hyd... quality-of-life...	18 Years - 120 Years	Eastern Cooperative Oncology Group
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck	NCT00006361	Carcinoma of Un... Head and Neck C... Non-melanomatou...	semaxanib	18 Years -	National Cancer Institute (NCI)
Cancer Genetic Testing in Ethnic Populations	NCT04475640	Breast Carcinom... Carcinoma of Un... Central Nervous... Digestive Syste... Genitourinary S... Head and Neck C... Malignant Brain... Malignant Femal... Malignant Muscu... Malignant Solid... Skin Carcinoma	Biospecimen Col... Genetic Testing	18 Years -	Mayo Clinic
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	NCT00004922	Carcinoma of Un... Neuroendocrine ... Neuroendocrine ...	irinotecan hydr...	18 Years -	Memorial Sloan Kettering Cancer Center
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)	NCT05461430	Pleural Effusio... Ascites, Malign... Carcinoma Carcinoma, Hepa... Carcinoma, Rena... Carcinoma, Rena... Carcinoma, Smal... Carcinoma, Non-... Carcinoma, Panc... Carcinoma, Neur... Carcinoma, Thym... Carcinoma, Panc... Carcinoma Breas... Carcinoma, Ovar... Carcinoma Bladd... Carcinoma of Un... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of Es... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Carcinoma of th... Cholangiocarcin... Melanoma Mesothelioma Pancreatic Canc...		18 Years -	Travera Inc
Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin	NCT00004005	Carcinoma of Un... Colorectal Canc... Unspecified Adu... Unspecified Chi...	fluorouracil irinotecan hydr... leucovorin calc... conventional su... radiation thera...	- 24 Years	St. Jude Children's Research Hospital
Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor	NCT00047125	Carcinoma of Un...	radiation thera...	18 Years - 120 Years	European Organisation for Research and Treatment of Cancer - EORTC

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: